Диссертация (1140907), страница 19
Текст из файла (страница 19)
Maclnture, C.P. Chu, M.A. Burgess // Epidemiol. Infec. - 2003. Vol. 131, № l.-C. 675-682.159. Modelling the impact of a combined varicella and zoster vaccinationprogramme on the epidemiology of varicella zoster virus in England / A. Jan vanHoeka [et al.] // Vaccine. – 2011. – V.
29, № 13. – P. 2411–2420.160. Morrow, T. Herpes zoster vaccine brings relief for the elderly / T.Morrow // Manag. Care. - 2006. - Vol. 15, № 12. - P. 57-8.161. Mossong, J. Seroprevalens and forse jf infection of varicella - zostervirus in Luxembourg / J. Mossong, L. Puts, F. Schneider // Epidemiol. Infec. —2004. — Vol. 132, № 6.-C. 1121-1127.162. Nagane, Y. Case of herpes zoster associated Guillain-Barresyndrome with a relapse of eruptions after intravenous immunoglobulin therapy/ Y.
Nagane, K. Utsugisawa, D; Obara // Rinsho Shinkeigaku. - 2006. - Vol. 46,№ 9. - P. 664-7.163. Necrosis of nose skin after varicella zoster infection: a case report / B.J.Snel et al. / Journal of Plastic, Reconstructive & Aesthetic Surgery. – 2010. - V.63, № 5. – P. e445–e447.124164. Pagani J.M. Highly active antiretroviral therapy-induced immunerecovery in an HIV-positive patient with a history of herpes zoster ophthalmicus /J.
M.Pagani, J. Qian Duan // Optometry Journal of the American OptometricAssociation. – 2011. – V. 82, №3. - P. 77–82.165. Pavan-Langston, D. Herpes zoster ophthalmicus / D. Pavan-Langston //Neurology. - 1995. - Vol. 45, № 8. -P. 50-51166. Persistence of varicella-zoster virus viraemia in patients with herpeszoster / M.L. Quinlivana [et al.] // Journal of Clinical Virology.
– 2011. - Vol 50,№ 2. - P. 130–135.167. Quinlivan, M. Molecular studies of Varicella zoster virus / M.Quinlivan, J. Breuer // Rev. Med. Virol. - 2006. - Vol. 16, № 4. - P. 225-50.168. Rapid contamination of varicella — zoster virus DNA from apatient with herpes zoster / T. Yoshikava, M. Ihira, K. Suzuki [et al.] // J.
Med.Virol. - 2001. - Vol. 63, № l.-C. 64—66.169. Rare differential diagnosis of a radicular spine syndrome: herpeszoster radiculitis / P. Koch, O. Diedrich, P.H. Pennekamp, A. Schmitz // Z.Orthop. Ihre. Grenzgeb. - 2006. - Vol. 144, № 6. - P. 583-6.170.
Relationship between preexisting anti-varicella-zoster virus (VZV)antibody and clinical VZV reactivation in hematopoietic stem celltransplantation recipients / M. Onozawa, S. Hashino, M. Takahata [et al.] // J.Clin. Microbiol. - 2006. - Vol. 44, № 12.-P. 4441-3.171. Rice P.S Ultra-violet radiation is responsible for the differences inglobal epidemiology of chickenpox and the evolution of varicella-zoster virus asman migrated out of Africa / P.S Rice // Virology. – 2011. – V.
8. – P. 189.172. Risk factors for postherpetic neuralgia in patients with herpes zoster /B.F. Jung, R.W. Johnson, D.R. Griffin, R.H. Dworkin // Neurology, - 2004. - ^ Vol.62, №9. -P. 1545-51.125173. Romito L.M. Cutaneous herpes zoster and implantable pulse generator /L.M. Romito, AlAlbanese // Technology at the Neural Interface. – 2010. – V. 13,№ 2. – P. 99-101.174. Safety profile of live varicella virus vaccine (Oka/Merck): Five-yearresults of the European Varicella Zoster Virus Identification Program (EU VZVIP)/ N. Goullereta [et al.] // Vaccine.
– 2010. – V. 28, № 36. – P. 5878–5882.175. Safety, tolerability, and immunogenicity after 1 and 2 doses of zostervaccine in healthy adults ≥60 years of age / J. N. Vermeulena [et al.] // Vaccine. –2012 – V. 30. – P. 904– 910176. Santiago-Pérez S. Herpes zoster-induced abdominal wall paresis:Neurophysiological examination in this unusual complication / S.
Santiago-Pérez,R. Nevado-Estévez, C. Pérez-Conde // J Neurol Sci. - V. 312, № 1–2, 2012, - P.177–179.177. Schmader, K. Herpes Zoster in older adults / K. Schmader // Clin.Infect. Diseases.-2001.-Vol. 32, № 10.-P. 1481-1486.178. Seroprevalence of varicella-zoster virus in Korea / Won Suk Choi [etal.] // Journal of Medical Virology. – 2010. – V. 82, № 12. – P. 2123-2126.179. Seroprevalens of antibody to varicella zoster virus in England andWales and young adults / A.J.
Vyse, N.G. Gay, L.M. Hesketh [et al.] //Epidemiol. Infec. - 2004. - Vol. 132, № 6. - P. 1129-1134.180. Study — epidemiology of neuropathic pain in patients with herpeszoster and post herpetic neuralgia in São Paulo, Brazil / Neto J. [et al.] EuropeanJournal of Pain. – 2010. - V. 4, № 1. – P. 73-74.181. The epidemiology of herpes zoster in 226 children with acutelymphoblastic leukemia / G. V. Sørensen [et al.] // Pediatric Blood & Cancer.
–2011. – V. 57,№ 6,- P. 993–997.182. The impact of varicella zoster virus: Chronic pain / W. Opsteltena [etal.] // Journal of Clinical Virology. – 2010. – V. 48, Suppl.1. - P. S8–S13.126183. The role of solar ultraviolet irradiation in zoster / M. Zak-Prelich,J.L. Bor- cowski, F. Alexander, M. Norval // Epidemiol. Infec. - 2002. - Vol.129, № 3. - P. 593-597.184. Thermography as a predictor of postherpetic neuralgia in acute herpeszoster patients: a preliminary study / J. Park [et al.] // Skin Research andTechnology. - 2012. – V. 18. – P.
88–93.185. Valomaciclovir versus valacyclovir for the treatment of acute herpeszoster in immunocompetent adults: a randomized, double-blind, active-controlledtrial / S.K. Tyring [et al.] // Journal of Medical Virology. – 2012. – V. 84, - P.1224–1232.186. Varicella - zoster virus infection of human dorsal root ganglia invivo / L.
Zerboni, Ku Chai-Chi, C.D. Jones [et al.] // Proc. Nat. Acad. Sci. USA.- 2005. -Vol. 102, № 18. - P. 6490-6495.187. Varicella infection in adult renal allograft recipients: experience atone center / A. Rodriguez-Moreno, A.I. Sanchez-Fructuoso, N. Calvo [et al.] //Transplant. Proc. -2006. - Vol. 38, № 8. - P. 2416-8.188. Varicella transmission in two sample s of children with socialbehavior in the State of Sao Paolo, Brazil / A.L.F. Yu, M. Amaki, M.N.Burratini [et al.] // Epidemiol. Infec.
- 2001. - Vol. 127, № 3. - P. 493-500.189. Varicella zoster virus immunity in multinational health care workers ofa Saudi Arabion hospital / M. Almuneef, J. Dillon, M.F. Abbas, Z. Memish // Am.J. Infec. Contr. -2003. - Vol. 31, № 3. - P. 375-381.190. Varicella-zoster virus antigen expression of eccrine gland and ductepithelium in herpes zoster lesions / C. Horie [et al.] // British Journal ofDermatology. – 2011. - V. 165, № 4.
– P. 802–807.191. Varicella-Zoster Virus-Specific Cell-Mediated Immune Reponses inHIV-Infected Adults / De Castro [et al.] // AIDS Research and HumanRetroviruses. - 2011. – V. 27, № 10. – P. 1089-1097.127192. Vijayalekshmi Sujatha. Herpes zoster ophthalmicus: clinical profile inadults less than 30 years of age / Vijayalekshmi Sujatha // Our Dermatol Online. –2012 –V. 3, № 1, - P. 9.193. Wagenpfeil, S. Effect of varicella vaccination on herpes zosterincidence / S.
Wagenpfeil, A. Neiss, P. Wutzler // Clin. Microbiol. Infect. - 2004.- Vol. 10. - P. 954-960.194. Wassilew, S.W. Zoster-associated neuralgias / S.W. Wassilew // J.Dtsch. Dermatol. Ges. - 2006. - Bd. 4, № 10. - S. 871-9.195. Whitley R.J. [et al.] Management of herpes zoster and post-herpeticneuralgia now and in the future / Journal of Clinical Virology. – 2010. – V. 48,Suppl. 1. - Pages S20–S28.196. Wiley J. Herpes zoster of the penis: an immunohistochemistrydiagnosis/ J. Wiley // Journal of Cutaneous Pathology.
– 2012. – V. 39. - P.811–812.197. Wolfe, F. Rates and predictors of herpes zoster in patients withrheumatoid arthritis and non-inflammatory musculoskeletal disorders / F. Wolfe,K. Michaud, E.F. Chakravarty // Rheumatology (Oxford). - 2006. - Vol. 45, №11. - P. 1370-5.198. Wonderful, S. Effects of varjcella vaccination on herpes zosterincidence / S. Wonderful, A. Neiss, P. Wutzler // Clin. Microbiol. Infect. - 2004: № 10. - P.
954-960.199. Zak-Prelich, M. Local immune responses and systemic responses inzoster: relationship to the development of postherpetic neuralgia / M. Zak-Prelich,R.C. Mc Kenzie, A. Sysa-Jedrzelovska // Clin. Exp. Immunol. - 2003. - Vol. 131,№2.-P. 318-323.200. Zoster Study Group, Valomaciclovir Versus Valacyclovir for theTreatment of Acute Herpes Zoster in Immunocompetent Adults: A Randomized,Double-Blind, Active-Controlled Trial / Tyring S.K.
[et al.] // Journal of MedicalVirology. – 2012. – V. 84, - P. 1224–1232.128.















